On Demand | 6th International Meeting on Lung Cancer

49
Speakers
2
Days
157
Registrations
14
Sponsors
Τα πιστοποιητικά είναι διαθέσιμα!
Δεν υπάρχουν διαθέσιμα δεδομένα. Επικοινωνήστε μαζί μας μέσω email ζητώντας την πιστοποίησή σας ή καλέστε μας για να σας βοηθήσουμε.

Chairs D. Papadatos-Pastos (UK), G. Tsakonas (SWE)
08.30-08.50 Genomic profile of SCLC and treatment of LS-SCLC F. I. Dimitrakopoulos (GR)
08.50-09.10 Novel therapeutic advances in ES-SCLC I. Korantzis (GR)
09.10-09.20 Comments/Discussion

Chairs P. Shaw (UK), D. Papadatos-Pastos (UK), N. Panagiotopoulos (UK)
09.20-09.40 HIT meso P. Shaw (UK)
09.40-10.00 Case Mesothelioma S. Zemerly (UK)

Chairs: F. Dimitrakopoulos (GR), I.Metaxas (SUI)
11.00-11.20 The future of the treatment of ALK+ NSCLC: An update D. Thomaidou (GR)
11.20-11.40 EGFR mutant NSCLC: Overcoming the resistance to 3rd generation EGFR TKIs and new therapeutic options G. Tsakonas (SWE)
11.40-12.10 The importance of co-mutations in NSCLC N. Karachaliou (DE)
12.10-12.30 Comments/Discussion

Chairs A. Kotsakis (GR), F. Dimitrakopoulos (GR)
10.30-10.50 Τhe treatment of ALK+ NSCLC: An update P. Christopoulos (DE)
10.50-11.10 EGFR mutant NSCLC: Intensifying First-Line Treatment in EGFR-Driven Lung Cancer D. Papadatos-Pastos (UK)
11.10-11.30 The treatment of EGFR mutant NSCLC beyond the first line G. Tsakonas (SWE)
11.30-11.40 Comments/Discussion

Chairs A. Boutis (GR), G. Fotopoulos (CY)
11.40-12.00 Case 1 (KRAS G12C) G. Oikonomopoulos (GR)
12.00-12.20 Case 2 (ROS1-repotrectinib) E. Fergadis (GR)
12.20-12.40 Case 3 (HER2) G. Fotopoulos (CY)
12.40-13.00 Case 4 (c-MET) N. Asimakopoulou (GR)
13.00-13.10 Discussion: O. Fiste (GR), P. Christopoulos (DE), G. Maravelis (GR), P. Constantoulakis (GR)

Chair V. Georgoulias (GR), P. Constantoulakis (GR)
13.10-13.30 ctDNA for the Detection of Minimal Residual Disease (MRD) S. Giannoulakis (GR)
13.30-13.50 The liquid biopsy as a tool for early cancer detection A. Markou (GR)
13.50-14.10 Homologous Recombination Deficiency: a more universal therapeutic target in cancer cells? A. Klinakis (GR)
14.10-14.20 Comments/Discussion

Chairs Ph. Koinis (GR), V. Georgoulias (GR)
15.20-15.40 The new landscape of ADCs in NSCLC A. Grivas (GR)
15.40-16.00 Lung Cancer Pipeline; Future breakthroughs under development Ch. Michailidi (GR)
16.00-16.10 Discussion

Chairs F.I. Dimitrakopoulos (GR), D. Papadatos-Pastos (UK)
16.10-16.30 The need for a Thoracic research network V. Georgoulias (GR) F.I. Dimitrakopoulos (GR)
16.30-16.50 Clinical significance of Patras Immunotherapy Score (PIOS) & PDCD1 gene SNPs in NSCLC patients F.I. Dimitrakopoulos (GR)
16.50-17.10 HRD and immunotherapy in early early NSCLC (Pathology and Molecular Biology projects) V. Anastasopoulou (GR) I. Pateras (GR), A. Klinakis (GR)
17.10-17.40 Holistic liquid biopsy approach in patients with NSCLC A. Markou (GR), G. Kallergi (GR) A. Xagara / A. Kotsaki’s group (GR)

Chairs Κ. Tsapakidis (GR), Ch. Panopoulos (GR)
18.20-18.40 Adjuvant & peri-operative immunotherapy in operable NSCLC: The Future G. Evangelou (GR)
18.40-19.00 Radio-chemotherapy in non-operable locally advanced NSCLC A.-M. Shiarli (CY)
19.00-19.15 Comments/Discussion

Chairs P. Christopoulos (DE), E. Fergadis (GR)
08.30-08.50 Treatment of ALK early-stage NSCLC: A changed landscape A. Koulouris (SWE)
08.50-09.10 Treatment of EGFR mutant early-stage NSCLC Th. Tegos (GR)
09.10-09.30 The future of oncogene-driven stage I - IIIC NSCLC with TKIs beyond EGFR & ALK G. Fotopoulos (CY)
09.30-09.40 Comments / Discussion

Chairs P. Christopoulos (DE), E. Fergadis (GR)
Setting the survival standards in NSCLC Ο. Fiste (GR)
Sponsored by MSD

Chairs Α. Tsaroucha (GR), Ι. Georgakopoulos (GR)
10.10-10.30 Interventional Pulmonology management of malignant airway obstruction: Palliative or Therapeutic approach? Gr. Stratakos (GR)
10.30-10.50 The role of interventional radiologist in thoracic oncology A. Diamantopoulos (UK)
10.50-11.10 Pain management in cancer patients Z. Κοntouli (GR)
11.10-11.20 Discussion

Chairs P. Christopoulos (DE), F.I. Dimitrakopoulos (GR)
11.50-12.20 Accurate testing in NSCLC correlates with survival? A real word case for EGFR at Evangelismos Hospital Th.Tegos (GR)
12.20-12.50 Modulation of the Microbiome to improve Immunotherapy efficacy H. Charalambous (CY)
12.50-13.20 Challenges for the thoracic surgeon In the era of neoadjuvant treatment N. Panagiotopoulos (UK)
13.20-14.30 Summary of exchange sessions - general discussion / comments

Chairs D. Papadatos-Pastos (UK), N. Panagiotopoulous (UK)
16.00-16.20 Case 1 Adjuvant immunotherapy I. Vathiotis (GR)
16.20-16.40 Case 2 Peri-operative S. Arora (UK)
16.40-17.00 Case 3 Lung cancer and pseudoprogression in immunotherapy G. Christodoulopoulos (GR) / K.Tsapakidis (GR)
Board A. Charpidou (GR), E. Zervas (GR), K.Tsapakidis (GR), K. Papagiannopoulos (UK), A. Dimopoulos (GR)

Chairs A. Kotsakis (GR), P. Savvides (US)
17.00-17.20 Immunotherapy: State of the art in metastatic lung cancer in the 1st line setting E. Fergadis (GR)
17.20-17.40 Therapeutic options after immunotherapy failure Ch. Charalambous (CY)
17.40-18.00 IO in metastatic frail lung cancer patients D. Papadatos-Pastos (UK)
18.00-18.10 Comments / Discussion

Chairs Ch. Charalambous (CY), D. Papadatos-Pastos (UK)
18.30-19.00 Cellular therapies in lung cancer M. Al Bakir (UK)
19.00-19.30 Vaccines in lung cancer V. Karantza (US)

Al Bakir M.
MD, PhD, Consultant Medical Oncologist, University College London Hospitals NHS Foundation Trust, Researcher, Francis Crick Institute & UCL Cancer Institute, UK
Anastasopoulou V.
Postdoctoral Researcher, Hellenic Oncology Research Group, Athens, Greece
Arora S.
Oncology, Resident Medical Officer, The London Clinic, UK
Asimakopoulou N.
MD, PhD, Medical Oncologist, 1st Oncology Dpt, Metropolitan General, Athens, Greece
Boutis A.
Consultant Medical Oncologist, Director, 3rd Med. Oncology Dept., “Theagenio” Anticancer Hospital of Thessaloniki, Greece
Charalambous C.
BM, MRCP, FRCR, Consultant Clinical Oncologist, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Charpidou A.
MD, PhD, FCCP, Pulmonologist, Professor (Assoc) Medical Oncology, Head of Clinical Research Bureau, 3rd Dpt Internal Medicine and Laboratory, Medical School, National and Kapodistrian University of Athens, “Sotiria” Hospital, Athens, Greece
Christodoulopoulos G.
Oncology Resident, University Hospital of Larissa, Greece
Christopoulos Ch.
Head of Radiation Oncology Department, GHI Le Raincy-Montfermeil, Head of Oncology-Hematology Department, President of the Cancer Coordination Committee, GHT Grand Paris Nord-Est
Constantoulakis P.
PhD, Scientific Director, GENOTYPOS MSA
Diamantopoulos A.
MD, PhD, EBIR, FRCR, FCIRSE, Consultant Interventional Radiologist at Guy’s and St Thomas’ NHS Foundation Trust, Honorary Clinical Senior Lecturer στο King’s College London, UK
Dimitrakopoulos F. I.
MD, PhD, Medical Oncologist, Division of Oncology & Molecular Oncology Laboratory, Department of Medicine, University of Patras, Greece
Dimopoulos A.
Radiation Oncologist, Head of Department, Metropolitan Hospital Athens, Greece, Venia Docendi University of Vienna, Austria, Fmr ESTRO Faculty Member
Evangelou G.
MD, MSc, PhD, Medical Oncologist, 3rd Department of Medicine, NKUA, Sotiria Hospital, Athens, Greece
Fergadis E. G.
Medical Oncologist, Consultant, “Metaxa” Hospital, Piraeus, Greece
Fiste O.
MD, MSc, PhD, Medical Oncologist, 3rd Department of Internal Medicine and the Affiliated Laboratory, School of Medicine, National and Kapodistrian University of Athens, “Sotiria” Hospital, Athens, Greece
Fotopoulos G.
Assistant Professor of Medicine in the Division of Hematology/Oncology at Ut Health San Antonio, USA, Medical Oncology Consultant, BOCOC, Cyprus
Georgakopoulos I.
Assistant Professor of Radiation Oncology, National and Kapodistrian University of Athens, “Aretaieio” Hospital, Athens, Greece
Georgoulias V.
Professor Emeritus of Medical Oncology, University of Crete, Heraklion, Greece
Giannoulakis S.
Training & Development Manager, Genekor, Greece
Grivas A.
MD, Medical Oncologist Consultant, 2nd department of Medical Oncology, “Agios Savvas” Anticancer Hospital, Athens, Greece
Kallergi G.
Associate Professor of Biochemistry, Department of Biology, University of Patras, Greece
Karantza V.
MD, PhD, Professor of Medicine, Rutgers New Jersey Medical School, USA
Klinakis A.
PhD, Investigator, Biomedical Research Foundation of the Academy of Athens, Greece
Koinis F.
MD, PhD, Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
Kontouli Z.
MD, PhD, FIP, Director of Interventional Pain Clinic, Athens Medical Centre, Clinical Associate, 3rd Department of Medicine, University of Athens, Greece
Korantzis I.
MD, MSc, PhD, Consultant Medical Oncologist, “Saint Luke’s” Hospital, Thessaloniki, Greece
Kotsakis Α.
MD, PhD, Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larissa, Thessaly, Greece
Koulouris A.
MD, Oncologist, Theme Cancer, Karolinska University Hospital / Department of Oncology - Pathology, Karolinska Institutet, Sweden
Maravelis G.
MD, PhD, Deputy Director, Radiation Oncology Department, “Metropolitan” Hospital, Piraeus, Greece
Markou Y.
Consultant Medical Oncologist, MRCP, FRCR, Cyprus
Michailidi Ch.
MSc, PhD, Oncology Medical Lead | Greece, Cyprus, Malta, Pfizer Hellas
Oikonomopoulos G.
Consultant in Medical Oncology, MSc, 2nd Oncology Department, Metropolitan Hospital, N. Faliro, Greece
Panagiotopoulos N.
PhD, FICS, FSSO, Thoracic and Robotic Surgeon, Cleveland Clinic London, UK
Panopoulos C.
MD, PhD, Director, Oncology Department, “Euroclinic, Athens, Greece
Papadatos-Pastos D.
MRCP(UK), PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, UK
Papagiannopoulos K.
MBCHB, MD, MMED THORAX, CTH Cardiothoracics, Consultant Thoracic Surgeon, Director Thoracic Surgery Euroclinic LTD Athens GR, Past Clinical Director Thoracic Surgery Leeds UK, Past President and Treasurer European Society of Thoracic Surgeons, Director Central Fund Archdiocese of Great Britain and Thyateira
Pateras I.
Pathologist, Assοciate Professor, 2nd Department of Pathology, “Attikon” University Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Savvides P.
MD, PhD, MPH, Senior Associate Consultant, Thoracic H&N Medical Oncology, Mayo Clinic Arizona, USA
Shaw P.
FRCR, FRCP, PhD, Consultant Clinical Oncologist, Early Phase Drug RT Lead, RT, Research Director, Lung Trial Portfolio, Lead, Honorary Senior Lecturer, Bioscience, Cardiff University, Wales, UK
Shiarli A.M.
MBChB, BSc (Hons), MRCP (UK), FRCR, Consultant Clinical Oncologist, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Skoulidis F.
MD, PhD, Associate Professor, Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, USA
Stratakos G.
MD, PhD, FCCP, Professor of Respiratory Medicine and Interventional Pulmonology, National and Kapodistrian University of Athens, Head Interventional Pulmonology Unit -1st Respir. Med. Dept, N.K. University of Athens, “Sotiria” Hospital, Athens, Greece. President, European Association for Bronchology and Interventional Pulmonology
Tegos Th.
MD, PhD, Medical Oncologist, Evangelismos General Hospital, Athens, Greece
Tsakonas G.
MD, Senior Consultant, Lung Oncology Center, Theme Cancer Karolinska University Hospital, Associate Professor in Oncology, Department of Oncology and Pathology Karolinska Institutet, Stockholm, Sweden
Tsapakidis K.
Consultant Medical Oncologist, University of Thessaly - Faculty of Medicine, Dpt of Medical Oncology, University Hospital of Larissa, Greece
Tsaroucha A.
MD, MSc, PhD, Pulmonologist - Intensivist, Director of NHS, 2nd Pulmonary Department, “Sotiria” Hospital, Athens, Greece
Vathiotis I.
MD, MSc, PhD, Medical Oncologist, Scientific Associate, 3rd Department of Internal Medicine and the Affiliated Laboratory, School of Medicine, National and Kapodistrian University of Athens, “Sotiria” Hospital Athens, Greece
Xagara Α.
PhD, Molecular Biologist, Postdoctoral Researcher, Department of Medical Oncology, University General Hospital of Larissa, Thessaly, Greece
Zemerly S.
Oncology, Resident Medical Officer, The London Clinic, UK
Zervas E.
MD, Pulmonologist, Director of 7th Pulmonary Dept. and Bronchoscopic Unit “Christos Gagas”, “Sotiria” Hospital, Athens, Greece

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details
Sponsors